US2013251749A1PendingUtilityA1
Methods and compositions for chlamydial antigens as reagents/strategies for diagnosis and treatment of chlamydial infection and disease
Est. expiryMay 1, 2027(~0.8 yrs left)· nominal 20-yr term from priority
Inventors:Guangming Zhong
A61K 39/118G01N 2333/295A61P 37/04G01N 33/56927A61P 31/04
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides Chlamydia proteins and methods of use in diagnostic and detection assays as well as in treatment and immunization protocols.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 - 20 . (canceled)
21 . A method of eliciting an immune response in a subject, comprising administering to the subject an effective amount of an isolated Chlamydia trachomatis CT812 protein, thereby eliciting an immune response in the subject.
22 . A method of treating chlamydial infection in a subject, comprising administering to the subject an effective amount of an isolated Chlamydia trachomatis CT812 protein, thereby treating chlamydial infection in the subject.
23 . The method of claim 21 , wherein the subject is a human.
24 . The method of claim 22 , wherein the subject is a human.Join the waitlist — get patent alerts
Track US2013251749A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.